Entries by John Santilli

First Report Managed Care Panel: Are Stand-alone PBMs in Peril?

F Randy Vogenberg, PhD, RPh, NICH founding partner and principal, Institute for Integrated Healthcare (IIH), joined an expert payer roundtable panel to discuss recent shifts in the landscape and what it might mean for stand-alone pharmacy benefit managers. The discussion covers recent industry news from Express Scripts, Anthem, Inc. CVS Health, IngenioRx and what organizations should […]

Dr. Vogenberg Gives Patient, Plan Sponsor Perspective to Study of Economic Impact Study Comparing Ovarian Cancer Testing Methods

American Health & Drug Benefits October 2017 issue features an original research study analyzing the economic impact of increased utilization of multivariate assay testing to guide the treatment of ovarian cancer. NICH founding partner Dr. Randy Vogenberg is highlighted as the Stakeholder Perspective in the publication, where he discusses the findings as they relate to plan sponsors […]

Healthcare council unveils a unique employer-provider interaction framework to develop relationships and promote patient care

We’re excited to share news about Hospital Quality Foundation (HQF), a not-for-profit council driving significant innovation in a new approach to employer and healthcare provider relationships. This just-launched interaction framework will offer tools to help reduce costs, promote more effective patient care, and develop a better overall delivery process. NICH will be offering support to HQF and […]

NICH Presents to Global Audience at Nicholas Hall OTC Conference

NICH founding partner Dr. Randy Vogenberg recently participated in the first North American OTC Conference produced by Nicholas Hall, in collaboration with Everything Health in Morristown, NJ. A wide variety of multinational firms and insurers were in attendance for his speech, which was also streamed around the world. Dr. Vogenberg discussed the topic “Access Trends for […]

Dr. Vogenberg Quoted in BioPharm Insight on Zejula Scrutiny

Investigative biotech and pharma news source BioPharm Insight recently quoted Dr. Randy Vogenberg in a piece on ovarian cancer drug Zejula (niraparib), its pricing strategy, and potential payers’ reaction. Dr. Vogenberg is a principle at Institute for Integrated Healthcare and founding partner of NICH. Many experts say the recently FDA-approved drug may face additional scrutiny for […]

Dr. Vogenberg Quoted in Health Care Mega Mergers Article

NICH founding partner Dr. Vogenberg weighed in on Managed Health Care’s recent article “Aetna-Humana/Anthem-Cigna: Is This the End of Mega Mergers?” Diversification will be essential going forward, according to F Randy Vogenberg, PhD, RPh, principal at the Institute for Integrated Healthcare. Big payers “have to diversify and do a better job of managing risk. They […]